• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Advanced Search Include Citations

Tools

Sorted by:
Try your query at:
Semantic Scholar Scholar Academic
Google Bing DBLP
Results 1 - 10 of 3,263
Next 10 →

invasive breast cancer

by L Martin, B Green, C Renshaw, D Lowe, P Rudl, Sj Leinsterl, J Winstanley
"... Summary The intensity of angiogenesis as measured by the density of microvessels has been reported to be associated with a poor prognosis in invasive breast cancer in some, but not all, studies. The reasons for these discrepancies may be variations in the methodologies used. The monoclonal antibody ..."
Abstract - Add to MetaCart
Summary The intensity of angiogenesis as measured by the density of microvessels has been reported to be associated with a poor prognosis in invasive breast cancer in some, but not all, studies. The reasons for these discrepancies may be variations in the methodologies used. The monoclonal antibody

and early invasive breast carcinomas

by T Walsh, Ra Walker, Ja Shaw
"... Summary We have used polymerase chain reaction (PCR) analysis to study the incidence of allelic imbalance at four polymorphic microsatellite markers on chromosome 6q25.1-27, three dinucleotide repeats and one trinucleotide repeat, for microdissected tumour foci from a group of 75 'early ' ..."
Abstract - Add to MetaCart
; breast carcinomas. The tumours comprised 16 preinvasive cases of ductal carcinoma in situ (DCIS) and 59 mammographically detected early invasive carcinomas. Loss of heterozygosity (LOH) was detected at all four loci and in all types and grade of disease. The frequency of LOH ranged from 23 % to 50

measurements in invasive breast carcinoma∗

by Pauliina Kronqvist, Teijo Kuopio, Yrjo ̈ Collan, Csaba Horvath , 1997
"... The reproducibility of nuclear morphometric ..."
Abstract - Add to MetaCart
The reproducibility of nuclear morphometric

Unopposed Estrogen Therapy and the Risk of Invasive Breast Cancer

by MD, MPH; Wendy Y Chen , MD, DrPH; Joann E Manson , ScD; Susan E Hankinson , PhD; Bernard Rosner , MD, DrPH; Michelle D Holmes , MD, DrPH; Walter C Willett , MD, DrPH Graham A Colditz
"... Background: Although short-term unopposed estrogen use does not seem to increase breast cancer risk, the effect of longer-term estrogen use remains unclear. We sought to assess the relationship between longer-term use of unopposed estrogen and the risk of invasive breast cancer over an extended fol ..."
Abstract - Add to MetaCart
Background: Although short-term unopposed estrogen use does not seem to increase breast cancer risk, the effect of longer-term estrogen use remains unclear. We sought to assess the relationship between longer-term use of unopposed estrogen and the risk of invasive breast cancer over an extended

Declining Use of Mastectomy for Invasive Breast Cancer in

by Leslie A. Gaudette, Ru-nie Gao Md, Andrea Spence Msc, Fan Shi, Helen Johansen Phd, Ivo A. Olivotto
"... Objective: To evaluate the rate and magnitude of change in surgical practice for breast cancer in Canada in relation to publication dates of clinical trials and consensus confer-ences. Methods: Hospital separations with a diagnosis of invasive breast cancer were extracted from the Hospital Morbidity ..."
Abstract - Add to MetaCart
Objective: To evaluate the rate and magnitude of change in surgical practice for breast cancer in Canada in relation to publication dates of clinical trials and consensus confer-ences. Methods: Hospital separations with a diagnosis of invasive breast cancer were extracted from the Hospital

Like Subtype of Invasive Breast Carcinoma

by Gilks C, Rijn Mvd, Gamze Karaca, Tina Hernandez-boussard, Joseph Ragaz, Torsten O. Nielsen, Forrest D. Hsu, Gamze Karaca, Zhiyuan Hu
"... All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately. ..."
Abstract - Add to MetaCart
All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately.

relation to risk of invasive breast cancer

by Stephanie E Nelson, Michael N Gould, John M Hampton, Amy Trentham-dietz, Open Access
"... A case-control study of the HER2 Ile655Val polymorphism in ..."
Abstract - Add to MetaCart
A case-control study of the HER2 Ile655Val polymorphism in

clinical outcomes in invasive breast cancer

by Zakaria Einbeigi
"... High levels of γ-glutamyl hydrolase (GGH) are Conclusion: These data show for the first time that cytoplasmic GGH might play a relevant role in the Shubbar et al. BMC Cancer 2013, 13:47 ..."
Abstract - Add to MetaCart
High levels of γ-glutamyl hydrolase (GGH) are Conclusion: These data show for the first time that cytoplasmic GGH might play a relevant role in the Shubbar et al. BMC Cancer 2013, 13:47

Microvessel quantitation in invasive breast cancer by staining for factor

by unknown authors
"... Summanr The clinical importance of microvessel quantitation as a prognostic indicator in invasive breast cancer was examined. This study included 155 patients with invasive breast cancer. with a median follow-up of 82 months. Microvessels were identified by immunohistochemical staining for factor VI ..."
Abstract - Add to MetaCart
Summanr The clinical importance of microvessel quantitation as a prognostic indicator in invasive breast cancer was examined. This study included 155 patients with invasive breast cancer. with a median follow-up of 82 months. Microvessels were identified by immunohistochemical staining for factor

Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer

by Jiping Wang, Joseph P. Costantino, Elizabeth Tan-chiu, D. Lawrence Wickerham Soonmyung Paik
"... Background: The risk of invasive breast cancer associated with benign breast disease (BBD) other than atypical hyperplasia and in situ breast cancer, especially with nonproliferative diagnosis, has not been explored extensively. This report evaluates the risk of breast cancer associated with this lo ..."
Abstract - Cited by 3 (2 self) - Add to MetaCart
Background: The risk of invasive breast cancer associated with benign breast disease (BBD) other than atypical hyperplasia and in situ breast cancer, especially with nonproliferative diagnosis, has not been explored extensively. This report evaluates the risk of breast cancer associated
Next 10 →
Results 1 - 10 of 3,263
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University